Thirty-four million of this money is actually for AIDS research, particularly research focused on the discovery of a new vaccine. It's also for preparing the low- and middle-income countries for clinical trials, once we have a vaccine. It will ensure that we have trained people to carry out these trials.
On November 25th, 2010. See this statement in context.